A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Sponsored by Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).
Enrolling at this location
Atlanta Research Center for Rheumatology
Marietta, Georgia
I'm interestedThis study also enrolls at 35 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.